Rigel Pharmaceuticals, Inc. (RIGL): Price and Financial Metrics

Rigel Pharmaceuticals, Inc. (RIGL)

Today's Latest Price: $3.48 USD

0.06 (-1.69%)

Updated Jan 27 9:13am

Add RIGL to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 239 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

RIGL Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for RIGL is 2.07 -- better than 74.83% of US stocks.
  • The ratio of debt to operating expenses for Rigel Pharmaceuticals Inc is higher than it is for about merely 22.92% of US stocks.
  • As for revenue growth, note that RIGL's revenue has grown 29.15% over the past 12 months; that beats the revenue growth of 83.89% of US companies in our set.
  • If you're looking for stocks that are quantitatively similar to Rigel Pharmaceuticals Inc, a group of peers worth examining would be MRIN, KOPN, MOSY, ATNX, and OIIM.
  • RIGL's SEC filings can be seen here. And to visit Rigel Pharmaceuticals Inc's official web site, go to www.rigel.com.

RIGL Stock Price Chart Interactive Chart >

Price chart for RIGL

RIGL Price/Volume Stats

Current price $3.48 52-week high $5.24
Prev. close $3.54 52-week low $1.23
Day low $3.48 Volume 13,237
Day high $3.48 Avg. volume 2,320,279
50-day MA $3.35 Dividend yield N/A
200-day MA $2.52 Market Cap 588.05M

Rigel Pharmaceuticals, Inc. (RIGL) Company Bio

Rigel Pharmaceuticals, Inc. engages in the discovery and development of small-molecule drugs for the treatment of inflammatory and autoimmune diseases, immuno-oncology related diseases, and muscle disorders. The company was founded in 1996 and is based in South San Francisco, California.

RIGL Latest News Stream

Event/Time News Detail
Loading, please wait...

RIGL Latest Social Stream

Loading social stream, please wait...

View Full RIGL Social Stream

Latest RIGL News From Around the Web

Below are the latest news stories about Rigel Pharmaceuticals Inc that investors may wish to consider to help them evaluate RIGL as an investment opportunity.

Rigel Still Looks Modestly Undervalued Despite The Recent Rally

Rigel Pharmaceuticals (RIGL) has been a company I've followed for a long time and have off-and-on held a position in. I've also previously written about Rigel on two occasions. For this article, I wanted to dive deeper into Rigel’s Tavalisse opportunity in immune thrombocytopenic purpura ((ITP)) which is the main...

Andy Jones on Seeking Alpha | January 25, 2021

This former Michigan State University basketball player started selling mortgages in his 20s now he's worth more than $11 billion

The country's leader in the wholesale mortgage market is now a public company. Here's what the company's CEO Mat Ishbia told Yahoo Finance.

Yahoo | January 22, 2021

Rigel Pharmaceuticals (RIGL) Investor Presentation - Slideshow

The following slide deck was published by Rigel Pharmaceuticals, Inc. in conjunction with this event....

SA Transcripts on Seeking Alpha | January 19, 2021

Rigel Pharmaceuticals Provides Business Update

SOUTH SAN FRANCISCO, Calif., Jan. 11, 2021 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today provided a business update, including preliminary total revenue, TAVALISSE® (fostamatinib disodium hexahydrate) bottles sold for the quarter, Fast Track designation granted for warm…

PR Newswire | January 11, 2021

Rigel to Present at the 39th Annual J.P. Morgan Healthcare Conference

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Raul Rodriguez, the company's president and chief executive officer, is scheduled to present a company overview at the 39th Annual J.P. Morgan Virtual Healthcare Conference on Thursday, January 14, 2021 at 10:00 a.m. Eastern Time.

Yahoo | January 7, 2021

Read More 'RIGL' Stories Here

RIGL Price Returns

1-mo -5.69%
3-mo 38.10%
6-mo 51.30%
1-year 39.76%
3-year -19.44%
5-year 26.55%
YTD -0.57%
2020 63.55%
2019 -6.96%
2018 -40.72%
2017 63.03%
2016 -21.45%

Continue Researching RIGL

Here are a few links from around the web to help you further your research on Rigel Pharmaceuticals Inc's stock as an investment opportunity:

Rigel Pharmaceuticals Inc (RIGL) Stock Price | Nasdaq
Rigel Pharmaceuticals Inc (RIGL) Stock Quote, History and News - Yahoo Finance
Rigel Pharmaceuticals Inc (RIGL) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.8652 seconds.